Vivos Therapeutics, Inc. (VVOS)
Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014Q1-CY2014Q4-CY2013
Balance Sheet Date2025-Sep-302025-Jun-302025-Mar-312024-Dec-312024-Sep-302024-Jun-302024-Mar-312023-Dec-312021-Mar-312020-Dec-31
Fiscal PeriodQ3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024Q3-FY2024Q2-FY2024Q1-FY2024Q4-FY2023Q1-FY2021Q4-FY2020
Total Assets25,644,000$26,033,000$11,282,000$15,284,000$15,347,000$15,842,000$11,804,000$10,730,000$13,720,000$21,953,902$25,327,469$7,551,537$
Total Current Assets5,786,000$6,730,000$3,607,000$7,473,000$7,399,000$7,852,000$3,611,000$2,461,000$5,424,000$16,735,185$20,394,315$1,984,155$
Cash and Cash Equivalents3,087,000$4,402,000$2,342,000$6,260,000$6,311,000$6,903,000$2,611,000$1,643,000$3,519,000$14,058,028$18,205,668$469,353$
Receivables
Other Current Assets
Assets Held for Sale in Short Term
Total Noncurrent Assets19,858,000$19,303,000$7,675,000$7,811,000$7,948,000$7,990,000$8,193,000$8,269,000$8,296,000$5,218,717$4,933,154$5,567,382$
Goodwill8,450,000$8,450,000$2,843,000$2,843,000$2,843,000$2,843,000$2,843,000$2,843,000$2,843,000$2,671,434$2,671,434$2,671,434$
Other Intangible Assets2,172,000$2,225,000$358,000$370,000$383,000$395,000$408,000$420,000$302,000$301,690$270,121$689,151$
Physical Assets5,642,000$5,129,000$3,308,000$3,350,000$3,317,000$3,259,000$3,332,000$3,314,000$3,082,000$1,058,160$871,597$1,139,501$
Other Noncurrent Assets
Assets Held for Sale in Long Term
Total Liabilities23,112,000$21,450,000$6,875,000$7,330,000$7,682,000$9,495,000$11,222,000$10,319,000$8,919,000$7,613,453$8,410,110$9,177,929$
Total Current Liabilities7,437,000$6,426,000$4,701,000$4,978,000$5,126,000$6,643,000$8,070,000$7,289,000$6,813,000$7,295,471$7,823,049$9,093,683$
Accounts Payable2,103,000$1,763,000$1,206,000$1,098,000$1,075,000$2,028,000$2,499,000$2,145,000$1,411,000$869,679$781,364$1,083,422$
Short Term Debt
Short Term Capital Lease Obligations734,000$654,000$467,000$477,000$485,000$484,000$483,000$474,000$419,000$
Other Current Liabilities
Total Noncurrent Liabilities15,675,000$15,024,000$2,174,000$2,352,000$2,556,000$2,852,000$3,152,000$3,030,000$2,106,000$317,982$587,061$84,246$
Long Term Debt8,379,000$7,760,000$1,200,000$1,200,000$1,200,000$1,200,000$105,906$423,095$3,709,535$
Long Term Capital Lease Obligations2,866,000$2,814,000$932,000$1,035,000$1,158,000$1,280,000$1,399,000$1,521,000$1,994,000$
Other Noncurrent Liabilities1,400,000$1,400,000$
Total Equity2,532,000$4,583,000$4,407,000$7,954,000$7,665,000$6,347,000$582,000$411,000$46,000$2,106,000$6,993,000$4,801,000$25,539,000$14,340,449$16,917,359$(1,511,586$)(2,943,059$)
Equity to Minority
Equity to Common Shareholders2,532,000$4,583,000$4,407,000$7,954,000$7,665,000$6,347,000$582,000$411,000$46,000$2,106,000$6,993,000$4,801,000$25,539,000$14,340,449$16,917,359$(1,511,586$)(2,943,059$)
Additional Paid-In Capital120,995,000$117,647,000$112,458,000$112,141,000$109,025,000$105,091,000$97,396,000$93,462,000$84,269,000$53,072,597$52,250,266$20,333,548$
Retained Earnings(118,464,000$)(113,064,000$)(108,051,000$)(104,187,000$)(101,360,000$)(98,744,000$)(96,814,000$)(93,051,000$)(79,468,000$)(38,733,970$)(35,334,728$)(23,277,851$)
Treasury Stock
Capital Lease Obligations1,512,000$1,764,000$1,882,000$1,995,000$